相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system
Hajime Kato et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2022)
Tumor-Induced Osteomalacia
Pablo Florenzano et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
The Effects of Storage Time and Repeated Freeze-Thaw Cycles on Intact Fibroblast Growth Factor 23 Levels
Rong Tang et al.
BIOPRESERVATION AND BIOBANKING (2021)
Jury still out on whether FGF23 is a direct contributor, a useful or neither
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL (2021)
Fibroblast growth factor 23, the time is right for a second wind
Marc Vervloet
KIDNEY INTERNATIONAL (2021)
Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
Michael R. Laurent et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23
Nobuaki Ito et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2021)
Serum intact fibroblast growth factor 23 in healthy paediatric population
Malgorzata Stanczyk et al.
OPEN MEDICINE (2021)
Fibroblast growth factor 23: are we ready to use it in clinical practice?
Annet Bouma-de Krijger et al.
JOURNAL OF NEPHROLOGY (2020)
Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3
Matilde de las Rivas et al.
NATURE CHEMICAL BIOLOGY (2020)
Fibroblast Growth Factor-23 and a Vegetarian Diet
Shuchi Anand et al.
JOURNAL OF RENAL NUTRITION (2020)
Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
Alison M. Boyce et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein-a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism
E. Cavalier et al.
OSTEOPOROSIS INTERNATIONAL (2020)
FGF23 measurement in chronic kidney disease: What is it really reflecting?
Marc G. Vervloet
CLINICA CHIMICA ACTA (2020)
FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference
Marie-Liesse Piketty et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Validation of Fibroblast Growth Factor 23 Assays
Ishwarlal Jialal
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
FGF23: Clinical usefulness and analytical evolution
Charlotte Fauconnier et al.
CLINICAL BIOCHEMISTRY (2019)
Biological variation of intact fibroblast growth factor 23 measured on a fully automated chemiluminescent platform
Antonin Jabor et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2019)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Pre-analytical stability of FGF23 with the contemporary immunoassays
Niek F. Dirks et al.
CLINICA CHIMICA ACTA (2019)
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
Brian Czaya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinical utility of bone markers in various diseases
M. C. Vlot et al.
BONE (2018)
Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis
Wan-Chuan Tsai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23)
Josef van Helden et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2018)
The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
Matthew J. Damasiewicz et al.
BMC NEPHROLOGY (2018)
24-hour profile of serum sclerostin and its association with bone biomarkers in men
C. Swanson et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Evaluation of a New Fully Automated Assay for Plasma Intact FGF23
Jean-Claude Souberbielle et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Stability of Fibroblast Growth Factor 23 in Human Plasma
Salena Cui et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2017)
Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type
D. El-Maouche et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Pathogenesis and diagnostic criteria for rickets and osteomalacia-proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society
Seiji Fukumoto et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2015)
Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry
Karl Eckberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription
Tomer Meir et al.
KIDNEY INTERNATIONAL (2014)
Reduced Renal α-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism
Hirokazu Sakan et al.
PLOS ONE (2014)
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
Vincent S. Tagliabracci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Variability of New Bone Mineral Metabolism Markers in Patients Treated with Maintenance Hemodialysis: Implications for Clinical Decision Making
Etienne Cavalier et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs
Edward R. Smith et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
FGF23 concentrations measured using intact assays similar but not interchangeable
Manish D. Sinha et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2013)
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
Justin Silver et al.
NATURE REVIEWS NEPHROLOGY (2013)
Evaluation of a new automated chemiluminescence immunoassay for FGF23
Yuichiro Shimizu et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
Edward R. Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
KLOTHO methylation is linked to uremic toxins and chronic kidney disease
Guang-Huar Young et al.
KIDNEY INTERNATIONAL (2012)
Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase
Dagmar-Christiane Fischer et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2012)
Instability of fibroblast growth factor-23 (FGF-23): Implications for clinical studies
Edward R. Smith et al.
CLINICA CHIMICA ACTA (2011)
Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
Marc G. Vervloet et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Three feedback loops precisely regulating serum phosphate concentration
Pablo A. Urena Torres et al.
KIDNEY INTERNATIONAL (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Evaluation of a Method for Fibroblast Growth Factor-23: A Novel Biomarker of Adverse Outcomes in Patients with Renal Disease
Sridevi Devaraj et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2010)
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Regina Goetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI
Judith Blaine et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Bone as an endocrine organ
Seiji Fukumoto et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Determination of fibroblast growth factor 23
Annemieke C. Heijboer et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients - Proposal of diagnostic criteria using FGF23 measurement
Itsuro Endo et al.
BONE (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Determination of the elimination half-life of fibroblast growth factor-23
Azarmindokht Khosravi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
1,25-dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism
Thomas K. Barthel et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Negative regulation of human parathyroid hormone gene promoter by vitamin D3 through nuclear factor Y
T Jääskeläinen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
FGF23 is processed by proprotein convertases but not by PHEX
A Beret-Pagès et al.
BONE (2004)
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
SG Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
KE White et al.
KIDNEY INTERNATIONAL (2001)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
T Yamashita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
